Market Overview

UPDATE: Deutsche Bank Reiterates Buy Rating, Raises PT on Health Management Associates

Related HMA
Benzinga's Volume Movers
US Stock Futures Rise Ahead Of International Trade Data

In a report published Friday, Deutsche Bank reiterated its Buy rating on Health Management Associates (NYSE: HMA), and slightly raised its price target from $11.00 to $12.00.

Deutsche Bank noted, “We are presenting updated estimates to include the impending Bayfront Medical Center acquisition in St. Petersburg, FL (expected closing end of Q1) and to conform our pro forma EPS estimates with First Call consensus and HMA's guidance format, which excludes meaningful use incentive payments and unusual swap expense. Despite the noise of HMA's government investigation and fall-out from the recent 60 Minutes story, we continue to like the risk/reward in HMA shares. We believe HMA's exposure to these issues will be small, while its growth potential is solid, especially in the context of margin upside from PPACA in 2014. Reiterate Buy.”

Health Management Associates closed on Thursday at $9.55.

Latest Ratings for HMA

DateFirmActionFromTo
Dec 2013Wells FargoDowngradesOutperformMarket Perform
Sep 2013Avondale PartnersDowngradesMarket OutperformMarket Perform
Aug 2013UBSDowngradesBuyNeutral

View More Analyst Ratings for HMA
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Price Target Analyst Ratings

 

Related Articles (HMA)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional